|
Drug repurposing for treatment of congenital vascular malformations
Reference #: 1659
The University of South Carolina is offering licensing opportunities for Drug Repurposing for Treatment of Congenital Vascular Malformations.
Background:
Congenital vascular malformations (CVM) are a major threat to public health with a 1.5% incident rate in the general population. Congenital capillary malformation (CM), a.k.a.,...
Published: 12/3/2025
|
Updated: 5/17/2024
|
Inventor(s): Wenbin Tan, Vi Nguyen, Chao Gao, Anil Jegga, Yunguan Wang, Sudhir Ghandikota, Marcelo Hochman
Keywords(s):
Category(s): Biomedical and Life Sciences, Health Sciences
|
|
Trigonelline mitigates cardiomyopathy caused by SARS-CoV-2 Spike protein under obesity
Reference #: 01642
The University of South Carolina is offering licensing opportunities for Trigonelline mitigates cardiomyopathy caused by SARS-CoV-2 spike protein under obesity.
Background:
Today, the spread of Coronavirus Disease 2019 (COVID-19) continues, and while millions of patients have recovered, a significant number experience prolonged...
Published: 6/5/2026
|
Updated: 5/17/2024
|
Inventor(s): Wenbin Tan, Vi Nguyen, Taixing Cui
Keywords(s):
Category(s): Health Sciences, Biomedical and Life Sciences
|
|
Retinol Acid Pathway Modulators for Treatment of Congenital Vascular Malformation
Reference #: 01657
The University of South Carolina is offering licensing opportunities for Retinol Acid Pathway Modulators for Treatment of Congenital Vascular Malformation.
Background:
Congenital vascular malformations (CVM) are a major threat to public health with a 1.5% incident rate in the general population. Congenital capillary malformation...
Published: 12/3/2025
|
Updated: 4/24/2024
|
Inventor(s): Wenbin Tan, Vi Nguyen, J. Stuart Nelson
Keywords(s):
Category(s): Biomedical and Life Sciences
|
|
Targeting Treatment For ADAM30 In Pathological Cells
Reference #: 01462
The University of South Carolina is offering licensing opportunities for Targeting treatment for ADAM30 in pathological cells
Background:
The treatment options for vascular malformations include conservative management, drug treatment, interventional radiology, laser therapy, excisional surgery and psychological treatment. However,...
Published: 7/10/2026
|
Updated: 5/7/2021
|
Inventor(s): Wenbin Tan, Elaine Taine, Hui Wang, Vi Nguyen, Xialing Cao
Keywords(s): a disintegrin and metalloprotease (ADAM), antibody, biomarker, cancer, inhibitor, vascular malformation
Category(s): Health Sciences, Biomedical and Life Sciences
|
|
Exosome-Delivered Targeting Treatment for Blood Vessels
Reference #: 01455
The University of South Carolina is offering licensing opportunities for exosome-delivered targeting treatment for blood vessels
Background:
Vascular malformations cause a variety of severe symptoms, depending on body location and types of vasculatures involved, which makes clinical management very challenging. The treatment options...
Published: 7/10/2026
|
Updated: 5/7/2021
|
Inventor(s): Wenbin Tan, Rong Yin, Li Meng
Keywords(s): congenital vascular anomalies, exosomes, laser, photodynamic therapy, targeting treatment
Category(s): Health Sciences, Biomedical and Life Sciences
|
|
Biomarkers for Congenital Vascular Malformations
Reference #: 01454
The University of South Carolina is offering licensing opportunities for Biomarkers for congenital vascular malformations
Background:
Vascular Malformations ae blemishes or masses on the body that may cause pain, swelling, or bleeding. VMs result from abnormal development in blood vessels, lymph vessels, or arteries, and are rare...
Published: 12/3/2025
|
Updated: 5/7/2021
|
Inventor(s): Wenbin Tan, Elaine Taine
Keywords(s): biomarker, congenital vascular malformations, diagnosis
Category(s): Biomedical and Life Sciences, Health Sciences
|